Founders Capital Management, LLC Abbott Laboratories Transaction History

Founders Capital Management, LLC

$571 Million
Q3 2024

A detailed history of Founders Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Founders Capital Management, LLC holds 30,895 shares of ABT stock, worth $3.55 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

30,895

Previous 31,727 2.62%

Holding current value

$3.55 Million

Previous $3.3 Million 6.86%

% of portfolio

0.62%

Previous 0.6%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$100.07 - $118.13 $83,258 - $98,284	-832 Reduced 2.62%	30,895 $3.52 Million
Q2 2024 Jul 17, 2024	SELL	$100.73 - $112.44 $27,398 - $30,583	-272 Reduced 0.85%	31,727 $3.3 Million
Q1 2024 Apr 22, 2024	BUY	$109.52 - $120.96 $29,351 - $32,417	268 Added 0.84%	31,999 $3.64 Million
Q4 2023 Jan 23, 2024	SELL	$90.19 - $110.4 $11,363 - $13,910	-126 Reduced 0.4%	31,731 $3.49 Million
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $12,036 - $14,442	-126 Reduced 0.39%	31,857 $3.09 Million
Q2 2023 Jul 26, 2023	BUY	$100.78 - $112.29 $12,698 - $14,148	126 Added 0.4%	31,983 $3.49 Million
Q4 2021 Jan 27, 2022	SELL	$115.53 - $141.46 $17,445 - $21,360	-151 Reduced 0.47%	31,857 $4.48 Million
Q3 2021 Oct 21, 2021	BUY	$116.66 - $129.06 $61,713 - $68,272	529 Added 1.68%	32,008 $3.78 Million
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $10,996 - $13,354	-120 Reduced 0.38%	31,479 $3.43 Million
Q1 2020 Apr 20, 2020	BUY	$62.82 - $91.86 $44,162 - $64,577	703 Added 2.28%	31,599 $2.49 Million
Q4 2019 Jan 08, 2020	SELL	$78.51 - $87.4 $3,218 - $3,583	-41 Reduced 0.13%	30,896 $2.68 Million
Q2 2019 Jul 11, 2019	BUY	$72.88 - $85.0 $38,407 - $44,795	527 Added 1.73%	30,937 $2.6 Million
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $11,456 - $13,850	-173 Reduced 0.57%	30,410 $2.43 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $665,761 - $754,211	-10,155 Reduced 24.93%	30,583 $2.21 Million
Q2 2018 Jul 09, 2018	SELL	$57.57 - $63.54 $21,876 - $24,145	-380 Reduced 0.92%	40,738 $2.49 Million
Q4 2017 Jan 10, 2018	SELL	$53.68 - $57.47 $61,195 - $65,515	-1,140 Reduced 2.7%	41,118 $2.35 Million
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $2.03 Million - $2.27 Million	42,258	42,258 $2.26 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management, LLC with notifications on news.

Account

Founders Capital Management, LLC Abbott Laboratories Transaction History